These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3030325)

  • 21. Long-term stability of the anti-influenza A compounds--amantadine and rimantadine.
    Scholtissek C; Webster RG
    Antiviral Res; 1998 Jun; 38(3):213-5. PubMed ID: 9754890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myxovirus structural investigations by spin probe methods. II. Influence of rimantadine on the structure of viral and artificial lipid membranes].
    Kharitonenkov IG; Poltorak VI; Ruuge EK
    Mol Biol (Mosk); 1979; 13(5):1035-40. PubMed ID: 228179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of amantadine, rimantadine and levodopa on the frequency of fibrillation potentials in denervated muscle.
    Yaar I
    Electroencephalogr Clin Neurophysiol; 1984 Feb; 57(2):174-7. PubMed ID: 6198158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza.
    Quarles JM; Couch RB; Cate TR; Goswick CB
    Antiviral Res; 1981 Sep; 1(3):149-55. PubMed ID: 7337431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.
    Cheung CL; Rayner JM; Smith GJ; Wang P; Naipospos TS; Zhang J; Yuen KY; Webster RG; Peiris JS; Guan Y; Chen H
    J Infect Dis; 2006 Jun; 193(12):1626-9. PubMed ID: 16703504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes.
    Garcia Gil M; Sanchez Crespo M
    Immunopharmacology; 1983 Dec; 6(4):317-25. PubMed ID: 6654649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amantadine may be lifesaving in severe influenza A.
    Cunha BA
    Clin Infect Dis; 2006 Nov; 43(10):1372-3. PubMed ID: 17051511
    [No Abstract]   [Full Text] [Related]  

  • 28. Electrorotation--a new method for investigating membrane events during thrombocyte activation. Influence of drugs and osmotic pressure.
    Egger M; Donath E; Ziemer S; Glaser R
    Biochim Biophys Acta; 1986 Sep; 861(1):122-30. PubMed ID: 3092858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
    Sauerbrei A; Haertl A; Brandstaedt A; Schmidtke M; Wutzler P
    Med Microbiol Immunol; 2006 Jun; 195(2):65-71. PubMed ID: 16059699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of rimantadine on the structure of model and biological membranes.
    Cherny VV; Paulitschke M; Simonova MV; Hessel E; Ermakov YuA ; Sokolov VS; Lerche D; Markin VS
    Gen Physiol Biophys; 1989 Feb; 8(1):23-37. PubMed ID: 2737460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.
    Dolin R; Reichman RC; Madore HP; Maynard R; Linton PN; Webber-Jones J
    N Engl J Med; 1982 Sep; 307(10):580-4. PubMed ID: 7050702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
    Intharathep P; Laohpongspaisan C; Rungrotmongkol T; Loisruangsin A; Malaisree M; Decha P; Aruksakunwong O; Chuenpennit K; Kaiyawet N; Sompornpisut P; Pianwanit S; Hannongbua S
    J Mol Graph Model; 2008 Oct; 27(3):342-8. PubMed ID: 18620883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
    Barr IG; Hurt AC; Iannello P; Tomasov C; Deed N; Komadina N
    Antiviral Res; 2007 Feb; 73(2):112-7. PubMed ID: 16963130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of the antiviral activity of rimantadine and bonafton].
    Il'enko VI; Platonov VG; Khomenkova IK
    Vopr Virusol; 1977; (2):223-8. PubMed ID: 898899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amantadine-resistant influenza A virus in Taiwan.
    Shih SR; Lee CN; Tsai HR; Chen GW; Tsao KC
    J Formos Med Assoc; 2001 Sep; 100(9):608-12. PubMed ID: 11695276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secondary structure of the M2 protein of influenza type A virus and its role in forming resistance to rimantadine and deitiforin].
    Kiselev OI; Mishin VP; Eroshkin VI; Kozeletskaia KN; Usova EV; Rudenko VI; Chupakhin ON
    Mol Biol (Mosk); 1994; 28(5):1009-13. PubMed ID: 7990823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectroscopic characterization of vesicle formation on heated human erythrocytes and the influence of the antiviral agent amantadine.
    Herrmann A; Lentzsch P; Lassmann G; Ladhoff AM; Donath E
    Biochim Biophys Acta; 1985 Jan; 812(1):277-85. PubMed ID: 2981546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relative potencies of anti-influenza compounds.
    Tisdale M; Bauer DJ
    Ann N Y Acad Sci; 1977 Mar; 284():254-63. PubMed ID: 280137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport of amantadine and rimantadine through the blood-brain barrier.
    Spector R
    J Pharmacol Exp Ther; 1988 Feb; 244(2):516-9. PubMed ID: 3346834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Channel activity of mirror-image M2 proton channel of influenza A virus is blocked by achiral or chiral inhibitors.
    Guo QY; Zhang LH; Zuo C; Huang DL; Wang ZA; Zheng JS; Tian CL
    Protein Cell; 2019 Mar; 10(3):211-216. PubMed ID: 29679235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.